Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Microsoft Research podcast examines AI in healthcare

AI summary

Microsoft Research introduced a podcast episode featuring Doug Burger, Ava Amini, Eric Horvitz and Eric Topol on the use of AI in medicine and biomedical research. The discussion covers AI-assisted diagnosis, medical imaging, biological foundation models, AI-guided drug discovery, patient adoption, data quality and the need for real-world validation.

In-depth insight

The episode provides a research-grounded overview of AI’s current and prospective roles in healthcare while explicitly identifying data, validation and adoption hurdles.

Technical advancement is moving at such a rapid pace that it can be challenging to define the tomorrow we’re working toward. In The Shape of Things to Come, Microsoft Research leader Doug Burger and experts from across disciplines tease out the thorniest AI issues facing technologists, policymakers, business decisionmakers, and other stakeholders today. The goal: to amplify the shared understanding needed to build a future in which the AI transition is a net positive.

Microsoft Principal Research Manager Ava Amini, Microsoft Chief Scientific Officer Eric Horvitz, and physician-scientist and Microsoft AI health advisor Eric Topol (opens in new tab) of Scripps Research join Burger to tackle a question with ramifications for every individual on the planet: What might the future of medicine look like with AI, and what needs to happen first?

Drawing from experiences in machine learning, bioscience, and clinical care, the group explores AI-assisted medical diagnosis, the untapped potential of leveraging AI in medical imaging, whole-patient models, virtual cells, and the role of biological foundation models in scientific discovery. The group also examines why promising research can be slow to reach patients, how AI could guide experiments and drug discovery, and why better biological data and real-world validation remain essential.

#Microsoft Research#The Shape of Things to Come#Scripps Research

Original · 41 min readRead the original
Group chat

No comments yet. Start the conversation.